Literature DB >> 15963062

Correlation between genotype, phenotype and sex of rearing in 111 patients with partial androgen insensitivity syndrome.

A Deeb1, C Mason, Y S Lee, I A Hughes.   

Abstract

OBJECTIVE: Partial androgen insensitivity syndrome (PAIS) is a heterogeneous group of intersex disorders characterized by a typical perineoscrotal hypospadias/micropenis phenotype, and a normal androgen-producing testis. Various mutations in the androgen receptor (AR) are known to cause PAIS. Phenotypic expression is widely variable and there are no agreed guidelines to determine the sex of rearing in individuals with borderline masculinization. We aimed to quantitatively assess the external genital phenotype in relation to AR genotype and sex of rearing and identify criteria that differentiate mutation positive (ARmt) from mutation negative (ARwt) PAIS patients. PATIENTS AND
DESIGN: Cases with a diagnosis of PAIS were identified from the Cambridge Intersex Database. An external masculinization score (EMS) was used to quantify the degree of undermasculinization. Family history of AIS and details of the sex of rearing were recorded. Androgen binding was analysed in fibroblasts obtained from genital skin biopsies and mutational analysis of the AR was performed on genomic DNA extracted from peripheral blood. EMS and sex of rearing were compared in cases with similar mutations reported on the McGill International Database.
RESULTS: Two hundred and sixty-three patients with PAIS were identified. Androgen receptor gene sequencing was performed in 111 patients. Twenty-seven (24%) had mutations. Family history of AIS was present in 61 and 21% of ARmt and ARwt patients, respectively. The median EMS was 3 in both groups. The majority of ARmt patients had abnormal binding and there was a tendency to a higher median testosterone rise on hCG stimulation in ARmt (9.3 nmol/l) compared with ARwt patients (6.9 nmol/l). All patients with EMS of 4 or more were raised as male but there was an overlap of sex of rearing in patients with an EMS less than 4. A wide variation of EMS in relation to genotype and sex of rearing was observed.
CONCLUSION: The phenotype in PAIS is extremely variable and is rarely predicted by the AR genotype. Apart from the family history, there are no specific criteria to differentiate ARwt from ARmt. Sex of rearing is not entirely dependent on the EMS. Cultural issues, other modifying genes and response to androgen trials might be influencing factors. Collaborative studies with uniform protocols are needed to investigate infants with PAIS. Documenting phenotype, surgical procedures and outcome criteria are necessary to enable decision-making on the sex of rearing in patients with a lower range EMS.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15963062     DOI: 10.1111/j.1365-2265.2005.02298.x

Source DB:  PubMed          Journal:  Clin Endocrinol (Oxf)        ISSN: 0300-0664            Impact factor:   3.478


  17 in total

1.  Beyond the Caster Semenya controversy: the case of the use of genetics for gender testing in sport.

Authors:  Ambroise Wonkam; Karen Fieggen; Raj Ramesar
Journal:  J Genet Couns       Date:  2010-09-08       Impact factor: 2.537

2.  Cell-line and tissue-specific signatures of androgen receptor-coregulator transcription.

Authors:  Jan-Hendrik Bebermeier; James D Brooks; Samuel E DePrimo; Ralf Werner; Uta Deppe; Janos Demeter; Olaf Hiort; Paul-Martin Holterhus
Journal:  J Mol Med (Berl)       Date:  2006-08-24       Impact factor: 4.599

Review 3.  Gender identity, gender assignment and reassignment in individuals with disorders of sex development: a major of dilemma.

Authors:  A D Fisher; J Ristori; E Fanni; G Castellini; G Forti; M Maggi
Journal:  J Endocrinol Invest       Date:  2016-06-10       Impact factor: 4.256

4.  The male reproductive system in classic galactosemia: cryptorchidism and low semen volume.

Authors:  Cynthia S Gubbels; Corrine K Welt; John C M Dumoulin; Simon G F Robben; Catherine M Gordon; Gerard A J Dunselman; M Estela Rubio-Gozalbo; Gerard T Berry
Journal:  J Inherit Metab Dis       Date:  2012-10-11       Impact factor: 4.982

5.  Three novel and two known androgen receptor gene mutations associated with androgen insensitivity syndrome in sex-reversed XY female patients.

Authors:  Balachandran Saranya; Gunasekaran Bhavani; Brindha Arumugam; Meena Jayashankar; Sathiyavedu Thyagarajan Santhiya
Journal:  J Genet       Date:  2016-12       Impact factor: 1.166

6.  Pubertal induction and transition to adult sex hormone replacement in patients with congenital pituitary or gonadal reproductive hormone deficiency: an Endo-ERN clinical practice guideline.

Authors:  A Nordenström; S F Ahmed; E van den Akker; J Blair; M Bonomi; C Brachet; L H A Broersen; H L Claahsen-van der Grinten; A B Dessens; A Gawlik; C H Gravholt; A Juul; C Krausz; T Raivio; A Smyth; P Touraine; D Vitali; O M Dekkers
Journal:  Eur J Endocrinol       Date:  2022-04-21       Impact factor: 6.558

7.  Apolipoprotein D (APOD) is a putative biomarker of androgen receptor function in androgen insensitivity syndrome.

Authors:  Mahesh Appari; Ralf Werner; Lutz Wünsch; Gunnar Cario; Janos Demeter; Olaf Hiort; Felix Riepe; James D Brooks; Paul-Martin Holterhus
Journal:  J Mol Med (Berl)       Date:  2009-03-30       Impact factor: 4.599

8.  Noncatalytic role of the FKBP52 peptidyl-prolyl isomerase domain in the regulation of steroid hormone signaling.

Authors:  Daniel L Riggs; Marc B Cox; Heather L Tardif; Martin Hessling; Johannes Buchner; David F Smith
Journal:  Mol Cell Biol       Date:  2007-10-15       Impact factor: 4.272

9.  Minor hypospadias: the "tip of the iceberg" of the partial androgen insensitivity syndrome.

Authors:  Nicolas Kalfa; Pascal Philibert; Ralf Werner; Françoise Audran; Anu Bashamboo; Hélène Lehors; Myriam Haddad; Jean Michel Guys; Rachel Reynaud; Pierre Alessandrini; Kathy Wagner; Jean Yves Kurzenne; Florence Bastiani; Jean Bréaud; Jean Stéphane Valla; Gérard Morisson Lacombe; Mattea Orsini; Jean-Pierre Daures; Olaf Hiort; Françoise Paris; Kenneth McElreavey; Charles Sultan
Journal:  PLoS One       Date:  2013-04-30       Impact factor: 3.240

10.  A Recurrent Germline Mutation in the 5'UTR of the Androgen Receptor Causes Complete Androgen Insensitivity by Activating Aberrant uORF Translation.

Authors:  Nadine C Hornig; Carine de Beaufort; Friederike Denzer; Martine Cools; Martin Wabitsch; Martin Ukat; Alexandra E Kulle; Hans-Udo Schweikert; Ralf Werner; Olaf Hiort; Laura Audi; Reiner Siebert; Ole Ammerpohl; Paul-Martin Holterhus
Journal:  PLoS One       Date:  2016-04-25       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.